Insmed Incorporated (0JAV.L)

USD 66.21

(-7.07%)

Inventory Summary of Insmed Incorporated

  • Insmed Incorporated's latest annual inventory in 2023 was 83.24 Million USD , up 19.06% from previous year.
  • Insmed Incorporated's latest quarterly inventory in 2024 Q3 was 98.47 Million USD , up 9.33% from previous quarter.
  • Insmed Incorporated reported annual inventory of 69.92 Million USD in 2022, up 4.35% from previous year.
  • Insmed Incorporated reported annual inventory of 67 Million USD in 2021, up 35.12% from previous year.
  • Insmed Incorporated reported quarterly inventory of 82.95 Million USD for 2024 Q1, down -0.35% from previous quarter.
  • Insmed Incorporated reported quarterly inventory of 98.47 Million USD for 2024 Q3, up 9.33% from previous quarter.

Annual Inventory Chart of Insmed Incorporated (2023 - 1999)

Historical Annual Inventory of Insmed Incorporated (2023 - 1999)

Year Inventory Inventory Growth
2023 83.24 Million USD 19.06%
2022 69.92 Million USD 4.35%
2021 67 Million USD 35.12%
2020 49.59 Million USD 75.16%
2019 28.31 Million USD 302.63%
2018 7.03 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD -100.0%
2006 576 Thousand USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%

Peer Inventory Comparison of Insmed Incorporated

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD -592.349%
Agios Pharmaceuticals, Inc. 19.07 Million USD -336.402%
Amicus Therapeutics, Inc. 59.69 Million USD -39.453%
Atara Biotherapeutics, Inc. 9.7 Million USD -757.696%
bluebird bio, Inc. 22.91 Million USD -263.227%
Cara Therapeutics, Inc. 2.82 Million USD -2851.01%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 78.426%
Myriad Genetics, Inc. 20.1 Million USD -314.169%
Neurocrine Biosciences, Inc. 38.3 Million USD -117.358%
Supernus Pharmaceuticals, Inc. 77.4 Million USD -7.544%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 98.999%
Waters Corporation 516.23 Million USD 83.874%
Thermo Fisher Scientific Inc. 5.08 Billion USD 98.364%
Biogen Inc. 2.52 Billion USD 96.706%
Nektar Therapeutics 16.1 Million USD -417.036%
Perrigo Company plc 1.14 Billion USD 92.703%
Dynavax Technologies Corporation 53.29 Million USD -56.217%
Illumina, Inc. 587 Million USD 85.818%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 10.37 Million USD -702.622%
Heron Therapeutics, Inc. 42.11 Million USD -97.692%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 92.481%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -656.938%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 96.774%
Esperion Therapeutics, Inc. 65.62 Million USD -26.858%
FibroGen, Inc. 41.56 Million USD -100.284%
Agilent Technologies, Inc. 1.03 Billion USD 91.926%
OPKO Health, Inc. 65.69 Million USD -26.715%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 6.616%
Exelixis, Inc. 17.32 Million USD -380.563%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 96.753%
Axsome Therapeutics, Inc. 15.13 Million USD -450.036%
Abeona Therapeutics Inc. -2.44 Million USD 3506.219%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 88.732%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD -192.869%
Sarepta Therapeutics, Inc. 322.85 Million USD 74.215%
Corcept Therapeutics Incorporated 7.73 Million USD -976.947%
Halozyme Therapeutics, Inc. 127.6 Million USD 34.759%
Blueprint Medicines Corporation 21.22 Million USD -292.254%
TG Therapeutics, Inc. 39.82 Million USD -109.045%
Incyte Corporation 62.97 Million USD -32.198%
Emergent BioSolutions Inc. 328.9 Million USD 74.689%